During the event, we held strategic meetings with key industry players to strengthen Cannava’s international presence, analyse regulatory and commercial trends in the European market, and identify new opportunities for cooperation and investment.

 

The consolidation of Europe — and Germany in particular — as one of the most dynamic markets for medical cannabis confirms the importance of continuing to work on the internationalisation of our company and on positioning Argentine production to meet pharmaceutical quality standards.

 

From Jujuy, we continue to promote a model of productive, scientific and industrial development that positions Argentina as a key player in the global medical cannabis supply chain.